The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2020

Filed:

Sep. 26, 2017
Applicant:

Diagnostic Hybrids, Inc., Athens, OH (US);

Inventors:

Leonard Kohn, Woodinville, OH (US);

James L. Brown, Athens, OH (US);

David R. Scholl, Athens, OH (US);

Yunsheng Li, Athens, OH (US);

Giorgio Napolitano, Pescara, IT;

Assignee:

Diagnostic Hybrids, Inc., Athens, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/566 (2006.01); C07K 14/72 (2006.01); C12Q 1/6883 (2018.01);
U.S. Cl.
CPC ...
G01N 33/566 (2013.01); C07K 14/72 (2013.01); C12Q 1/6883 (2013.01);
Abstract

The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays. Such improvements are based upon the superior performance of assays comprising a chimeric TSH receptor in the presence of a glucocorticoid including, but not limited to, dexamethasone.


Find Patent Forward Citations

Loading…